Hennewig Ulrike, Kaatsch Peter, Blettner Maria, Spix Claudia
German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Centre of the Johannes Gutenberg University Mainz, 55101, Mainz, Germany.
Radiat Environ Biophys. 2014 Aug;53(3):485-93. doi: 10.1007/s00411-014-0550-9. Epub 2014 May 27.
Radiotherapy (RT) has been associated with the development of solid second malignant neoplasms (SMNs) in childhood cancer survivors. The aim of this study was to analyse the effect of cumulative doses of previous RT received at the SMN body region, at all other body regions and at body regions adjacent to the SMN, on the risk of developing a solid SMN. A total of 190 cases diagnosed with a solid second malignant neoplasm in 1980-2002 were matched with 368 controls with single neoplasm from the database of the German Childhood Cancer Registry (GCCR) (33,809 patients at cut-off date). The GCCR registers approximately 97 % of all childhood malignancies which occur at an age of less than 15 years in Germany since 1980. It was found that 147 (77.4 %) cases had received RT compared to 208 (56.6 %) controls with cumulative focus doses from 8 to 110 Gy. Fifty per cent of the SMNs and 60 % of RT affected the head region. RT was shown to increase the risk of a solid second tumour within the body region of radiation by 5.3 % per Gy (odds ratio 1.053; 95 % confidence interval 1.036-1.071). With increasing age at diagnosis and with more recent treatment eras, this effect decreased. Cumulative RT doses received at all other body regions or only at body regions adjacent to the SMN did not show an additional effect on the risk of developing an SMN. It is thus concluded that RT is the main risk factor for the development of SMNs within the irradiated body region. Late effects surveillance of former patients should give special attention to the originally irradiated parts of the body.
放射治疗(RT)与儿童癌症幸存者发生实体性第二原发性恶性肿瘤(SMN)有关。本研究的目的是分析在SMN身体区域、所有其他身体区域以及与SMN相邻的身体区域接受的既往放疗累积剂量对发生实体性SMN风险的影响。在1980年至2002年期间诊断为实体性第二原发性恶性肿瘤的190例病例与来自德国儿童癌症登记处(GCCR)数据库(截止日期时为33,809例患者)的368例单发肿瘤对照进行匹配。GCCR登记了自1980年以来在德国发生的年龄小于15岁的所有儿童恶性肿瘤的约97%。结果发现,147例(77.4%)病例接受了放疗,而208例(56.6%)对照接受了累积焦点剂量为8至110 Gy的放疗。50%的SMN和60%的放疗影响头部区域。放疗显示每Gy使放疗身体区域内发生实体性第二肿瘤的风险增加5.3%(优势比1.053;95%置信区间1.036 - 1.071)。随着诊断时年龄的增加以及治疗时代的更新,这种影响会降低。在所有其他身体区域或仅在与SMN相邻的身体区域接受的放疗累积剂量对发生SMN的风险未显示出额外影响。因此得出结论,放疗是受照射身体区域内发生SMN的主要风险因素。对既往患者的晚期效应监测应特别关注身体最初接受照射的部位。